Design and Biological Evaluation of Piperazine-Bearing Nitrobenzamide Hypoxia/GDEPT Prodrugs: The Discovery of CP-506.

Ashoorzadeh, Amir; Mowday, Alexandra M; Abbattista, Maria R; Guise, Christopher P; Bull, Matthew R; Silva, Shevan; Patterson, Adam V; Smaill, Jeff B

Ashoorzadeh, Amir; Mowday, Alexandra M; Abbattista, Maria R; Guise, Christopher P; Bull, Matthew R; Silva, Shevan; Patterson, Adam V; Smaill, Jeff B.

Afiliação

Ashoorzadeh A; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Mowday AM; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1142, New Zealand.
Abbattista MR; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Guise CP; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1142, New Zealand.
Bull MR; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Silva S; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Patterson AV; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Smaill JB; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.

ACS Med Chem Lett ; 14(11): 1517-1523, 2023 Nov 09.

Article em En | MEDLINE | ID: mdl-37974941

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google